You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

newly diagnosed AML

Showing 76 - 100 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

nk/T-cell Lymphoma, Newly Diagnosed, Advanced Lymphoma Trial in Beijing (XPO1 inhibitor)

Recruiting
  • nk/T-cell Lymphoma
  • +2 more
  • XPO1 inhibitor
  • Beijing, Haidian, China
    ChinaPLAGH
Apr 18, 2023

Oncology, Psychological Distress Trial (mHealth-delivered music breathing therapy, Online educational modules)

Not yet recruiting
  • Oncology
  • Psychological Distress
  • mHealth-delivered music breathing therapy
  • Online educational modules
  • (no location specified)
Sep 19, 2023

Multiple Sclerosis Trial in Istanbul (Structured exercise training)

Not yet recruiting
  • Multiple Sclerosis
  • Structured exercise training
  • Istanbul, Turkey
    Feray Güngör
Jul 16, 2023

HIV, Hiv Trial (Community Antiretroviral Therapy)

Not yet recruiting
  • HIV Infections
  • Hiv
  • Community Antiretroviral Therapy
  • (no location specified)
Nov 6, 2023

Classic Hodgkin Lymphoma Trial (Concurrent penpulimab and AVD, Sequential penpulimab and AVD)

Not yet recruiting
  • Classic Hodgkin Lymphoma
  • Concurrent penpulimab and AVD
  • Sequential penpulimab and AVD
  • (no location specified)
Jul 10, 2023

Newly-diagnosed Ph+ Acute Lymphoblastic Leukemia Trial in Xi'an (Olverembatinib plus venetoclax and dexamethasone)

Recruiting
  • Newly-diagnosed Ph+ Acute Lymphoblastic Leukemia
  • Olverembatinib plus venetoclax and dexamethasone
  • Xi'an, Shannxi, China
    Department of Hematology, Xijing Hospital, Fourth Military Medic
Oct 9, 2023

Multiple Sclerosis (MS) Trial in Birmingham (Physical activity behavioral intervention in persons newly diagnosed with MS)

Recruiting
  • Multiple Sclerosis (MS)
  • Physical activity behavioral intervention in persons newly diagnosed with MS
  • Birmingham, Alabama
    University of Alabama at Birmingham
Jan 24, 2023

Clinical Pathways for Newly Diagnosed Multiple Myeloma

Not yet recruiting
  • Multiple Myeloma
  • Multiple Myeloma Without Mention of Remission
  • Multiple Myeloma Pathway
  • +2 more
  • (no location specified)
Nov 27, 2023

Glioblastoma Multiforme Trial (WP1066)

Not yet recruiting
  • Glioblastoma Multiforme
  • (no location specified)
May 18, 2023

Lymphoma, Mantle-Cell Trial in Shanghai (Zanubrutinib, Rituximab, Bendamustin)

Not yet recruiting
  • Lymphoma, Mantle-Cell
  • Shanghai, Shanghai, China
    Ruijin Hospital
Nov 14, 2023

Newly Diagnosed Peripheral T-cell Lymphoma Trial in Nanjing (CMOP+Chidamide)

Recruiting
  • Newly Diagnosed Peripheral T-cell Lymphoma
  • Nanjing, Jiangsu, China
    Hematological Department, People's Hospital of Jiangsu Province
Jun 1, 2023

PCNSL Trial in Shanghai (Zanubrutinib, Rituximab, Methotrexate)

Not yet recruiting
  • PCNSL
  • Shanghai, Shanghai, China
    Ruijin Hospital
Jun 8, 2023

Guiding the Treatment in Older Newly Diagnosed Multiple Myeloma

Not yet recruiting
  • Multiple Myeloma
  • Frailty
    • (no location specified)
    Oct 30, 2023

    Light Chain (AL) Amyloidosis, CCND1 Translocation, Venetoclax Trial (Venetoclax, Dexamethasone Oral)

    Not yet recruiting
    • Light Chain (AL) Amyloidosis
    • +2 more
    • (no location specified)
    Aug 16, 2023

    Non-hodgkin Lymphoma Trial (Methotrexate, Rituximab (where available), Ibrutinib)

    Not yet recruiting
    • Non-hodgkin Lymphoma
    • (no location specified)
    Aug 11, 2023

    ITP - Immune Thrombocytopenia Trial (hetrombopag 5mg po qd, High-dose Dexamethasone)

    Not yet recruiting
    • ITP - Immune Thrombocytopenia
    • hetrombopag 5mg po qd
    • High-dose Dexamethasone
    • (no location specified)
    Jul 5, 2023

    Newly Diagnosed AML With FLT3 Activating Mutations Trial in United States (crenolanib, cytarabine, daunorubicin)

    Completed
    • Newly Diagnosed AML With FLT3 Activating Mutations
    • Duarte, California
    • +8 more
    Jul 17, 2020

    Type 1 Diabetes Trial in Sacramento (personalized comprehensive diabetes support)

    Enrolling by invitation
    • Type 1 Diabetes
    • personalized comprehensive diabetes support
    • Sacramento, California
      University of California Davis
    Sep 24, 2023

    Newly Diagnosed Glioblastoma Trial ([177Lu]Lu-NeoB, [68Ga]Ga-NeoB, Temozolomide)

    Not yet recruiting
    • Newly Diagnosed Glioblastoma
    • (no location specified)
    Feb 13, 2023

    Acute Myeloid Leukemia, EBV-Positive Neoplastic Cells Present, HLA-A*0201 Positive Cells Present Trial in Seattle (Aldesleukin,

    Terminated
    Has Results
    • Acute Myeloid Leukemia
    • +4 more
    • Aldesleukin
    • +2 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Oct 15, 2021

    AI-ECG in a NEwly Diagnosed Heart Failure

    Recruiting
    • Heart Failure
    • Eko DUO
    • London, United Kingdom
      Imperial College London
    Apr 4, 2023

    Positron Emission Radiomics With PSMA Radioligands on Newly

    Not yet recruiting
    • Prostate Cancer
    • Immunohistochemistry (IHC) analysis
    • (no location specified)
    Apr 6, 2023

    Extensive Small Cell Lung Cancer Trial in Jinan (Adebelizumab+Carboplatin+Etoposide+Concurrent Radiotherapy)

    Recruiting
    • Extensive Small Cell Lung Cancer
    • Adebelizumab+Carboplatin+Etoposide+Concurrent Radiotherapy
    • Jinan, Shan Dong, China
      The First Affiliated Hospital of Shandong First Medical Universi
    Nov 6, 2023

    Type 2 Diabetes Trial in Roma (flash glucose monitoring continuous, capillary blood test, flash glucose monitoring intermittent)

    Recruiting
    • Type 2 Diabetes
    • flash glucose monitoring continuous
    • +2 more
    • Roma, Italy
      Fondazione Policlinico Universitario Campus Bio-Medico
    Oct 18, 2023

    Breast Cancer Stage IV Trial in Vienna (Datopotamab deruxtecan)

    Recruiting
    • Breast Cancer Stage IV
    • Datopotamab deruxtecan
    • Vienna, Austria
      AKH Universitaetsklinikum Vienna, Department f. Internal medicin
    May 19, 2023